Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review

February 2021 | 41 pages | ID: AF99E3B944CEN
GlobalData

Abstracts

Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Australian Pharmaceutical Industries Ltd (API) is an integrated healthcare service provider. The company produces, retails, markets and sells pharmaceutical, health and beauty care products. It markets these products under various brand such as Priceline & Priceline Pharmacy, Clearskincare, Soul Pattinson Chemist, Pharmacist Advice, Club Premium and Pharmacy Best Buys. API procures various health, beauty, and lifestyle products and sells them on retail basis. It also manufactures pharmaceutical products; and owns rights of medicines and consumer toiletries in New Zealand. The company also offers pharmacy services, professional care services and counselling for various patients related to specific medication needs. API is headquartered in Camberwell, Victoria, Australia.

Australian Pharmaceutical Industries Ltd Key Recent Developments

Oct 16,2020: Australian Pharmaceutical Industries : Trading update FY20
Jul 09,2020: API resignation of Director
Apr 23,2020: Australian Pharmaceutical Industries : 2020 half year results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Australian Pharmaceutical Industries Ltd - Key Facts
Australian Pharmaceutical Industries Ltd - Key Employees
Australian Pharmaceutical Industries Ltd - Key Employee Biographies
Australian Pharmaceutical Industries Ltd - Major Products and Services
Australian Pharmaceutical Industries Ltd - History
Australian Pharmaceutical Industries Ltd - Company Statement
Australian Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Australian Pharmaceutical Industries Ltd - Business Description
Geographical Segment: Australia
Performance
Overview
Geographical Segment: New Zealand
Performance
Overview
Australian Pharmaceutical Industries Ltd - Corporate Strategy
Australian Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Australian Pharmaceutical Industries Ltd - Strengths
Australian Pharmaceutical Industries Ltd - Weaknesses
Australian Pharmaceutical Industries Ltd - Opportunities
Australian Pharmaceutical Industries Ltd - Threats
Australian Pharmaceutical Industries Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Australian Pharmaceutical Industries Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 16, 2020: Australian Pharmaceutical Industries : Trading update FY20
Jul 09, 2020: API resignation of Director
Apr 23, 2020: Australian Pharmaceutical Industries : 2020 half year results

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Australian Pharmaceutical Industries Ltd, Key Facts
Australian Pharmaceutical Industries Ltd, Key Employees
Australian Pharmaceutical Industries Ltd, Key Employee Biographies
Australian Pharmaceutical Industries Ltd, Major Products and Services
Australian Pharmaceutical Industries Ltd, History
Australian Pharmaceutical Industries Ltd, Other Locations
Australian Pharmaceutical Industries Ltd, Subsidiaries
Australian Pharmaceutical Industries Ltd, Key Competitors
Australian Pharmaceutical Industries Ltd, Ratios based on current share price
Australian Pharmaceutical Industries Ltd, Annual Ratios
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Australian Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Australian Pharmaceutical Industries Ltd, Interim Ratios
Australian Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Australian Pharmaceutical Industries Ltd, Performance Chart (2016 - 2020)
Australian Pharmaceutical Industries Ltd, Ratio Charts

COMPANIES MENTIONED

Amway of Australia Pty Ltd
Suda Pharmaceuticals Ltd
Kazia Therapeutics Ltd
Discount Drug Stores Pty Ltd
Sigma Healthcare Ltd